Bank of New York Mellon’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-1,200
| Closed | -$9.74K | – | 4476 |
|
2023
Q1 | $9.74K | Hold |
1,200
| – | – | ﹤0.01% | 4357 |
|
2022
Q4 | $14.2K | Hold |
1,200
| – | – | ﹤0.01% | 4387 |
|
2022
Q3 | $17K | Hold |
1,200
| – | – | ﹤0.01% | 4466 |
|
2022
Q2 | $42K | Hold |
1,200
| – | – | ﹤0.01% | 4382 |
|
2022
Q1 | $48K | Hold |
1,200
| – | – | ﹤0.01% | 4528 |
|
2021
Q4 | $51K | Hold |
1,200
| – | – | ﹤0.01% | 4498 |
|
2021
Q3 | $81K | Hold |
1,200
| – | – | ﹤0.01% | 4364 |
|
2021
Q2 | $92K | Buy |
+1,200
| New | +$92K | ﹤0.01% | 4231 |
|
2019
Q4 | – | Sell |
-381
| Closed | -$19K | – | 4237 |
|
2019
Q3 | $19K | Hold |
381
| – | – | ﹤0.01% | 4176 |
|
2019
Q2 | $35K | Hold |
381
| – | – | ﹤0.01% | 4141 |
|
2019
Q1 | $56K | Sell |
381
-11
| -3% | -$1.62K | ﹤0.01% | 4072 |
|
2018
Q4 | $62K | Hold |
392
| – | – | ﹤0.01% | 4030 |
|
2018
Q3 | $96K | Hold |
392
| – | – | ﹤0.01% | 4035 |
|
2018
Q2 | $88K | Sell |
392
-71
| -15% | -$15.9K | ﹤0.01% | 4010 |
|
2018
Q1 | $113K | Buy |
463
+60
| +15% | +$14.6K | ﹤0.01% | 4030 |
|
2017
Q4 | $124K | Buy |
403
+11
| +3% | +$3.39K | ﹤0.01% | 4027 |
|
2017
Q3 | $143K | Buy |
392
+222
| +131% | +$81K | ﹤0.01% | 3935 |
|
2017
Q2 | $62K | Buy |
+170
| New | +$62K | ﹤0.01% | 4105 |
|
2016
Q4 | – | Sell |
-144
| Closed | -$34K | – | 4317 |
|
2016
Q3 | $34K | Sell |
144
-25
| -15% | -$5.9K | ﹤0.01% | 4177 |
|
2016
Q2 | $33K | Sell |
169
-20
| -11% | -$3.91K | ﹤0.01% | 4233 |
|
2016
Q1 | $81K | Hold |
189
| – | – | ﹤0.01% | 4003 |
|
2015
Q4 | $72K | Hold |
189
| – | – | ﹤0.01% | 4092 |
|
2015
Q3 | $51K | Hold |
189
| – | – | ﹤0.01% | 4185 |
|
2015
Q2 | $56K | Buy |
189
+19
| +11% | +$5.63K | ﹤0.01% | 4143 |
|
2015
Q1 | $47K | Buy |
+170
| New | +$47K | ﹤0.01% | 4134 |
|